MedPath

GLENMARK PHARMACEUTICALS (AUSTRALIA) PTY LIMITED

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

TGA:14

Drug Approvals

ARABITRO abiraterone acetate 500 mg film-coated tablet bottle (489666)

Product Name
ARABITRO abiraterone acetate 500 mg film-coated tablet bottle
Approval Date
May 22, 2025
TGA

BORTRACZO bortezomib 2.5 mg/1 mL solution for injection vial (444811)

Product Name
BORTRACZO bortezomib 2.5 mg/1 mL solution for injection
Approval Date
May 22, 2025
TGA

BORTRACZO bortezomib 3.5 mg/1.4 mL solution for injection vial (444812)

Product Name
BORTRACZO bortezomib 3.5 mg/1.4 mL solution for injection
Approval Date
May 22, 2025
TGA

ABIRATERONE VIATRIS abiraterone acetate 500 mg film-coated tablet bottle (453790)

Product Name
ABIRATERONE VIATRIS abiraterone acetate 500 mg film-coated tablet bottle
Approval Date
May 22, 2025
TGA

ARABITRO abiraterone acetate 250 mg tablet bottle (457885)

Product Name
ARABITRO abiraterone acetate 250 mg tablet bottle
Approval Date
May 21, 2025
TGA

ABIRATERONE VIATRIS abiraterone acetate 250 mg tablet bottle (453789)

Product Name
ABIRATERONE VIATRIS abiraterone acetate 250 mg tablet bottle
Approval Date
May 21, 2025
TGA

TRANAMEF tranylcypromine (as sulfate) 10 mg tablet bottle (444810)

Product Name
TRANAMEF tranylcypromine (as sulfate) 10 mg tablet bottle
Approval Date
Apr 16, 2025
TGA

DOFIDAZ diclofenac sodium 3% w/w gel tube (443217)

Product Name
DOFIDAZ diclofenac sodium 3% w/w gel tube
Approval Date
Mar 6, 2025
TGA

ATOVACUE atovaquone 750 mg/5 mL oral liquid suspension bottle (407150)

Product Name
ATOVACUE atovaquone 750 mg/5 mL oral liquid suspension bottle
Approval Date
Apr 9, 2024
TGA

SIBZEOS azelaic acid 150 mg/g gel tube (433350)

Product Name
SIBZEOS azelaic acid 150 mg/g gel tube
Approval Date
Jan 10, 2024
TGA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.